Innovate (NYSE:VATE) announced today that the U.S. Food and Drug Administration has approved the MediBeacon TGFR for the ...
CergenX announced today that the FDA granted breakthrough device designation for its Wave device for neonatal brain ...
Hosted on MSN4h
EBR’s US heart lead hopes tick up after wireless device gets nod for fast-track reimbursement pathwayCMS has accepted EBR's WiSE cardiac resynchronisation therapy (CRT) system into the fast-track TCET reimbursement pathway. ..
EBR Systems is girding for US FDA approval of its novel heart lead in April and commercialisation by the end of the year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback